Literature DB >> 6137689

Rapid desensitisation for desferrioxamine anaphylactoid reaction.

J Bousquet, M Navarro, G Robert, P Aye, F B Michel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6137689     DOI： 10.1016/s0140-6736(83)90785-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  The treatment of secondary hemochromatosis.

Authors:  Norbert Gattermann
Journal:  Dtsch Arztebl Int       Date:  2009-07-24       Impact factor: 5.594

Review 3.  A risk-benefit assessment of iron-chelation therapy.

Authors:  J B Porter
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.228
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.